The Martin Jädersten group is investigating biological and clinical aspects of acute myeloid leukemia (AML) and runs academic trials exploring novel treatment strategies. The team leader Martin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback